TenNor Therapeutics Ltd   Report issue

For profit Phase 2
Founded: Westfield NJ United States (2013)

Organization Overview

First Clinical Trial
2019
NCT03964493
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

TenNor Therapeutics Limited